Caffeine prevents acute mortality after TBI in rats without increased morbidity

Experimental Neurology

Volumn 234, Issue 1, 2012, Pages 161-168

  Lusardi, Theresa A ^a   Lytle, Nikki K ^a   Szybala, Cory ^a   Boison, Detlev ^a  

^a LEGACY RESEARCH   (United States)

Author keywords

Apnea; Caffeine; EEG; FPI; Neuroprotection; Traumatic brain injury

Indexed keywords

ADENOSINE; CAFFEINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APNEA; ARTICLE; BIOENERGETIC NETWORK HOMEOSTASIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG RESPONSE; ELECTROENCEPHALOGRAM; EPILEPSY; HISTOPATHOLOGY; HOMEOSTASIS; MALE; MORBIDITY; MORTALITY; MOTONEURON; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; EPILEPSY; EVOKED POTENTIALS; EXPLORATORY BEHAVIOR; MALE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 84857502482     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.12.026     Document Type: Article

References (58)

1. Al Moutaery K., Al Deeb S., Ahmad Khan H., Tariq M. Caffeine impairs short-term neurological outcome after concussive head injury in rats. Neurosurgery 2003, 53:704-711. discussion 711-702.
2. Barone J.J., Roberts H.R. Caffeine consumption. Food Chem. Toxicol. 1996, 34:119-129.
3. Barraco R.A., Janusz C.A., Schoener E.P., Simpson L.L. Cardiorespiratory function is altered by picomole injections of 5'-N-ethylcarboxamidoadenosine into the nucleus tractus solitarius of rats. Brain Res. 1990, 507:234-246.
4. Basheer R., Strecker R.E., Thakkar M.M., McCarley R.W. Adenosine and sleep-wake regulation. Prog. Neurobiol. 2004, 73:379-396.
5. Bell M.J., Kochanek P.M., Carcillo J.A., Mi Z., Schiding J.K., Wisniewski S.R., Clark R.S., Dixon C.E., Marion D.W., Jackson E. Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. J. Neurotrauma 1998, 15:163-170.
6. Bell M.J., Robertson C.S., Kochanek P.M., Goodman J.C., Gopinath S.P., Carcillo J.A., Clark R.S., Marion D.W., Mi Z., Jackson E.K. Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury. Crit. Care Med. 2001, 29:399-404.
7. Boison D. Adenosine as a neuromodulator in neurological diseases. Curr. Opin. Pharmacol. 2008, 8:2-7.
8. Boison D. The adenosine kinase hypothesis of epileptogenesis. Prog. Neurobiol. 2008, 84:249-262.
9. Boison D. Methylxanthines, seizures and excitotoxicity. Handb. Exp. Pharmacol. 2010, 200:251-266.
10. Boison D., Scheurer L., Zumsteg V., Rulicke T., Litynski P., Fowler B., Brandner S., Mohler H. Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6985-6990.
11. Boison D., Masino S.A., Geiger J.D. Homeostatic bioenergetic network regulation: a novel concept to avoid pharmacoresistance in epilepsy. Expert Opin. Drug Discov. 2011, 1-12.
12. Bonati M., Latini R., Tognoni G., Young J.F., Garattini S. Interspecies comparison of in vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse. Drug Metab. Rev. 1984, 15:1355-1383.
13. Clark R.S., Carcillo J.A., Kochanek P.M., Obrist W.D., Jackson E.K., Mi Z., Wisneiwski S.R., Bell M.J., Marion D.W. Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery 1997, 41:1284-1292. discussion 1292-1293.
14. Cotter G., Dittrich H.C., Weatherley B.D., Bloomfield D.M., O'Connor C.M., Metra M., Massie B.M. The PROTECT Pilot Study: a randomized, placebo-controlled, dose-finding study of the adenosine A(1) receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J. Card. Fail. 2008, 14:631-640.
15. D'Ambrosio R., Fairbanks J.P., Fender J.S., Born D.E., Doyle D.L., Miller J.W. Post-traumatic epilepsy following fluid percussion injury in the rat. Brain 2004, 127:304-314.
16. D'Ambrosio R., Hakimian S., Stewart T., Verley D.R., Fender J.S., Eastman C.L., Sheerin A.H., Gupta P., Diaz-Arrastia R., Ojemann J., Miller J.W. Functional definition of seizure provides new insight into post-traumatic epileptogenesis. Brain 2009, 132:2805-2821.
17. Dragunow M. Endogenous anticonvulsant substances. Neurosci. Biobehav. Rev. 1986, 10:229-244.
18. Dragunow M., Faull R.L.M. Neuroprotective effects of adenosine. Trends Pharmacol. Sci. 1988, 9:193-194.
19. Dunwiddie T.V. Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia 1980, 21:541-548.
20. During M.J., Spencer D.D. Adenosine: a potential mediator of seizure arrest and postictal refractoriness. Ann. Neurol. 1992, 32:618-624.
21. Elmenhorst D., Basheer R., McCarley R.W., Bauer A. Sleep deprivation increases A(1) adenosine receptor density in the rat brain. Brain Res. 2009, 1258:53-58.
22. 1 receptors are crucial in keeping an epileptic focus localized. Exp. Neurol. 2006, 200:184-190.
23. Fredholm B.B. Adenosine and neuroprotection. Int. Rev. Neurobiol. 1997, 40:259-280.
24. Fredholm B.B. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 2007, 14:1315-1323.
25. Fredholm B.B., Battig K., Holmen J., Nehlig A., Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 1999, 51:83-133.
26. Fredholm B.B., Chen J.F., Cunha R.A., Svenningsson P., Vaugeois J.M. Adenosine and brain function. Int. Rev. Neurobiol. 2005, 63:191-270.
27. Frey L.C. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 2003, 44:11-17.
28. Golarai G., Greenwood A.C., Feeney D.M., Connor J.A. Physiological and structural evidence for hippocampal involvement in persistent seizure susceptibility after traumatic brain injury. J. Neurosci. 2001, 21:8523-8537.
29. Gouder N., Scheurer L., Fritschy J.-M., Boison D. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J. Neurosci. 2004, 24:692-701.
30. Hasko G., Pacher P., Vizi E.S., Illes P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol. Sci. 2005, 26:511-516.
31. Headrick J.P., Bendall M.R., Faden A.I., Vink R. Dissociation of adenosine levels from bioenergetic state in experimental brain trauma: potential role in secondary injury. J. Cereb. Blood Flow Metab. 1994, 14:853-861.
32. Hirsch L.J. Is sudden unexpected death in epilepsy due to postictal brain shutdown?. Ann. Neurol. 2010, 68:773-775.
33. Jacobson K.A., von Lubitz D.K.J.E., Daly J.W., Fredholm B.B. Adenosine receptor ligands: differences with acute versus chronic treatment. TiPS 1996, 17:108-113.
34. Kharatishvili I., Nissinen J.P., McIntosh T.K., Pitkanen A. A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats. Neuroscience 2006, 140:685-697.
35. Kochanek P.M., Vagni V.A., Janesko K.L., Washington C.B., Crumrine P.K., Garman R.H., Jenkins L.W., Clark R.S., Homanics G.E., Dixon C.E., Schnermann J., Jackson E.K. Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 2006, 26:565-575.
36. Li W., Dai S., An J., Li P., Chen X., Xiong R., Liu P., Wang H., Zhao Y., Zhu M., Liu X., Zhu P., Chen J.F., Zhou Y. Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model. Neuroscience 2008, 151:1198-1207.
37. Lowenstein D.H. Epilepsy after head injury: an overview. Epilepsia 2009, 50(Suppl 2):4-9.
38. McCarley R.W. Neurobiology of REM and NREM sleep. Sleep Med. 2007, 8:302-330.
39. McIntosh T.K., Vink R., Noble L., Yamakami I., Fernyak S., Soares H., Faden A.L. Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 1989, 28:233-244.
40. Nantwi K.D. Recovery of respiratory activity after C2 hemisection (C2HS): involvement of adenosinergic mechanisms. Respir. Physiol. Neurobiol. 2009, 169:102-114.
41. Nilsson P., Hillered L., Ponten U., Ungerstedt U. Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J. Cereb. Blood Flow Metab. 1990, 10:631-637.
42. Pignataro G., Maysami S., Studer F.E., Wilz A., Simon R.P., Boison D. Downregulation of hippocampal adenosine kinase after focal ischemia as potential endogenous neuroprotective mechanism. J. Cereb. Blood Flow Metab. 2008, 28:17-23.
43. Pitkanen A., Lukasiuk K. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav. 2009, 14(Suppl 1):16-25.
44. Pitkanen A., Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol. 2011, 10:173-186.
45. Ribeiro J.A. What can adenosine neuromodulation do for neuroprotection?. Curr. Drug Targets CNS Neurol. Disord. 2005, 4:325-329.
46. Ribeiro J.A., Sebastiao A.M., de Mendonca A. Participation of adenosine receptors in neuroprotection. Drug News Perspect. 2003, 16:80-86.
47. Roth T., Roehrs T. Disorders of sleep and wakefulness. Principles of Neural Science 2000, 948-959. McGraw-Hill. E.R. Kandel, J.H. Schwartz, T.M. Jessell (Eds.).
48. Runold M., Lagercrantz H., Prabhakar N.R., Fredholm B.B. Role of adenosine in hypoxic ventilatory depression. J. Appl. Physiol. 1989, 67:541-546.
49. Sachse K.T., Jackson E.K., Wisniewski S.R., Gillespie D.G., Puccio A.M., Clark R.S., Dixon C.E., Kochanek P.M. Increases in cerebrospinal fluid caffeine concentration are associated with favorable outcome after severe traumatic brain injury in humans. J. Cereb. Blood Flow Metab. 2008, 28:395-401.
50. Santhakumar V., Bender R., Frotscher M., Ross S.T., Hollrigel G.S., Toth Z., Soltesz I. Granule cell hyperexcitability in the early post-traumatic rat dentate gyrus: the 'irritable mossy cell' hypothesis. J. Physiol. 2000, 524(Pt 1):117-134.
51. Schmidt B., Roberts R.S., Davis P., Doyle L.W., Barrington K.J., Ohlsson A., Solimano A., Tin W. Long-term effects of caffeine therapy for apnea of prematurity. N. Engl. J. Med. 2007, 357:1893-1902.
52. Shen H.-Y., Li T., Boison D. A novel mouse model for sudden unexpected death in epilepsy (SUDEP): role of impaired adenosine clearance. Epilepsia 2010, 51:465-468.
53. + channels specific to the neocortical epileptic focus after fluid percussion injury in the rat. J. Neurophysiol. 2010, 104:3345-3360.
54. Svenningsson P., Nomikos G.G., Fredholm B.B. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions. J. Neurosci. 1999, 19:4011-4022.
55. The Brain Trauma Foundation, The American Association of Neurological Surgeons The Joint Section on Neurotrauma and Critical Care. Resuscitation of blood pressure and oxygenation. J. Neurotrauma 2000, 17:471-478.
56. Tseng C.J., Biaggioni I., Appalsamy M., Robertson D. Purinergic receptors in the brainstem mediate hypotension and bradycardia. Hypertension 1988, 11:191-197.
57. Weber J.T., Rzigalinski B.A., Ellis E.F. Calcium responses to caffeine and muscarinic receptor agonists are altered in traumatically injured neurons. J. Neurotrauma 2002, 19:1433-1443.
58. Yee B.K., Singer P., Chen J.F., Feldon J., Boison D. Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. Eur. J. Neurosci. 2007, 26:3237-3252.